Lundbeck
HLUN-B.CO
#2375
Rank
S$8.40 B
Marketcap
$8.79
Share price
1.76%
Change (1 day)
25.63%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2023 (TTM): $0.48

According to Lundbeck 's latest financial reports the company's current EPS (TTM) is $0.48. In 2022 the company made an earnings per share (EPS) of $0.36 a decrease over its 2021 EPS that were of $0.81.

EPS history for Lundbeck from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$0.4833.25%
2022$0.36-55.47%
2021$0.81-51.83%
2020$1.69-28.01%
2019$2.34-44.08%
2018$4.1951.94%
2017$2.76126.64%
2016$1.22-120.84%
2015-$5.845622.18%
2014-$0.10-110.03%
2013$1.02-28.08%
2012$1.41-52.1%
2011$2.95-1.31%
2010$2.9915.61%
2009$2.59